TETRACYCLINE CAPSULE

국가: 캐나다

언어: 영어

출처: Health Canada

유효 성분:

TETRACYCLINE HYDROCHLORIDE

제공처:

AA PHARMA INC

ATC 코드:

J01AA07

INN (국제 이름):

TETRACYCLINE

복용량:

250MG

약제 형태:

CAPSULE

구성:

TETRACYCLINE HYDROCHLORIDE 250MG

관리 경로:

ORAL

패키지 단위:

100/1000/3000

처방전 유형:

Prescription

치료 영역:

TETRACYCLINES

제품 요약:

Active ingredient group (AIG) number: 0105499002; AHFS:

승인 상태:

APPROVED

승인 날짜:

2010-06-23

제품 특성 요약

PRESCRIBING INFORMATION
TETRACYCLINE
Tetracycline Hydrochloride Capsules USP
250 mg
Antibiotic
AA PHARMA INC.
DATE OF PREPARATION:
1165 Creditstone Road Unit #1
January 28, 2019
Vaughan, ON
L4K 4N7
Control No. : 216069
1
PRESCRIBING INFORMATION
TETRACYCLINE
Tetracycline Hydrochloride Capsules USP
250 mg
THERAPEUTIC CLASSIFICATION
Antibiotic
INDICATIONS AND CLINICAL USE
Many strains of bacteria have been shown to be resistant to the
tetracyclines. These
include certain strains of streptococci, staphylococci, pneumococci,
gonococci, and many
other gram negative organisms. Therefore, culture and sensitivity
testing are advised to
determine the susceptibility of the infecting organisms to
tetracyclines.
Chemotherapy should not be initiated until all the necessary
bacteriological investigations
have been started.
Microorganisms that have become insensitive to one tetracycline
invariably exhibit cross
resistance to other tetracyclines.
Some cross resistance between the tetracyclines and chloramphenicol
for gram-negative
organisms but not for gram-positive ones has been reported.
Tetracycline resistant
organisms are most likely to be acquired from other individuals in a
population where
tetracyclines have been widely used.
The tetracyclines are indicated in infections caused by the following
microorganisms:
2
Rickettsiae (Rocky Mountain spotted fever, typhus fever and the typhus
group, Q fever,
rickettsialpox, tick fevers), _M. pneumoniae_ (PPLO, Eaton agent),
agents of psittacosis and
ornithosis, agents of _L. venereum_ and _G. inguinale_, and the
spirochetal agent of relapsing
fever (_B. recurrentis_).
The following gram-negative organisms: _H. ducreyi_ (chancroid), _P.
pestis_ and _P. _
_tularensis_, _B. bacilliformis_. Bacteroides, _V. comma_ and _K.
fetus_, and Brucella organisms
(in conjunction with streptomycin).
The following gram-negative organisms, when bacteriologic testing
indicates appropriate
susceptibility to the drug: _E. coli_, _A. aerogenes_, Shigella, Mima,
Herellea, _H. influenzae_
(respiratory infec